News

RSV Vaccines for the World Conference - registration open

Posted on July 25, 2017

We are delighted to announce that online registration is open for the RSV Vaccines For The World conference 2017.

The goal of the conference is to bring together the scientific data and expertise (mainly focusing on vaccine developments) and connecting the stakeholders involved in RSV research. Researchers and physicians from all over the world are invited to join the discussions and share their knowledge. Specifically, scientists and physicians from low- and middle income countries (LMICs) and young researchers are being encouraged and supported to participate in this meeting. This year, the conference will be held on 29 November-01 December in Malaga, Spain.

read more

Real world evidence in medicine development - sign up now

Posted on July 21, 2017

IMI’s GetReal project (www.imi-getreal.eu) will run the first edition of an interactive online course entitled ‘Real-world evidence in medicine development’ from 2 October to 12 November 2017. Under the supervision of leading academics from the project, the course will provide participants with an introduction to the topics covered by GetReal, and present the current techniques, opportunities and challenges for the use of real-world evidence in medicine development.

Participants are expected to come from pharmaceutical companies, regulatory authorities, health technology assessment (HTA) bodies, patients organisations, consultancy companies and academia. As such, the course will foster discussion, interaction and mutual learning across all professionals involved in medicine development.

The course will focus on the following topics:
- overview of the medicine development landscape
- real-world evidence generation
- real-world evidence synthesis
- decision-making and weighing of evidence
- demonstrating relative effectiveness to decision-makers

Participants who successfully complete the assignments will be awarded a certificate. You can sign up now at www.imi-getreal.eu/Course

read more

Andrew Copestake joins Julius Clinical

Posted on May 05, 2017

Julius Clinical is proud to announce that Andrew Copestake has been appointed as our new Chief Business Development Officer starting immediately. He will be part of the Management team together with Messrs. Smink (CEO), Grobbee (CSO) and Van Dijk (COO).

read more

Julius Clinical Forms Alliance With Parexel

Posted on April 04, 2017

Alliance aims to strengthen global clinical trial services by aligning scientific and operational aspects of clinical trials

Utrecht, Netherlands, January 25, 2017 — Julius Clinical, a globally-operating Academic Research Organization (ARO), today announced it has entered into a non-exclusive alliance with PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organisation. The alliance provides biopharmaceutical companies an approach to aligning scientific and operational aspects of a clinical trial.

Through this alliance, Julius Clinical and PAREXEL offer biopharmaceutical companies a unified approach for studies by providing scientific leadership, peer-to-peer networks, operational excellence and global governance. Sponsor companies can reduce the challenge of managing multiple service providers on a single study by providing seamless access to the strengths of both organisations.  

“Julius Clinical’s scientific leaders have broad experience on study committees and are able to work effectively with international networks of thought leaders and high-recruiting sites. Combining Julius Clinical’s expertise and team with PAREXEL’s global operational capabilities, will result in efficiently designed and operated trials with high scientific standards and faster recruitment, accelerating development of products,” said Aize Smink, CEO, Julius Clinical.

“PAREXEL recognises that of paramount importance to our clients is access to a broad pool of highly engaged site networks and external academic leadership and capabilities to help deliver medicines that meet patients’ needs,” said Paul Evans, Ph.D., Corporate Vice President, Global Site Solutions, PAREXEL. “This alliance will provide our clients access to the complimentary expertise of both organizations in a streamlined manner, reducing the burden of managing multiple parties and thus the associated costs.”

read more